Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry
Despite the rising prevalence of methadone treatment in pregnant women with opioid use disorder, the effects of methadone on neurobehavioral development remain unclear. We developed a translational mouse model of prenatal methadone exposure (PME) that resembles the typical pattern of opioid use by p...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/66230 |
id |
doaj-5a76cf5be8ef4e9aa4a2a863c7ea3745 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gregory G Grecco Briana E Mork Jui-Yen Huang Corinne E Metzger David L Haggerty Kaitlin C Reeves Yong Gao Hunter Hoffman Simon N Katner Andrea R Masters Cameron W Morris Erin A Newell Eric A Engleman Anthony J Baucum Jiuen Kim Bryan K Yamamoto Matthew R Allen Yu-Chien Wu Hui-Chen Lu Patrick L Sheets Brady K Atwood |
spellingShingle |
Gregory G Grecco Briana E Mork Jui-Yen Huang Corinne E Metzger David L Haggerty Kaitlin C Reeves Yong Gao Hunter Hoffman Simon N Katner Andrea R Masters Cameron W Morris Erin A Newell Eric A Engleman Anthony J Baucum Jiuen Kim Bryan K Yamamoto Matthew R Allen Yu-Chien Wu Hui-Chen Lu Patrick L Sheets Brady K Atwood Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry eLife prenatal opioid development behavior motor cortex |
author_facet |
Gregory G Grecco Briana E Mork Jui-Yen Huang Corinne E Metzger David L Haggerty Kaitlin C Reeves Yong Gao Hunter Hoffman Simon N Katner Andrea R Masters Cameron W Morris Erin A Newell Eric A Engleman Anthony J Baucum Jiuen Kim Bryan K Yamamoto Matthew R Allen Yu-Chien Wu Hui-Chen Lu Patrick L Sheets Brady K Atwood |
author_sort |
Gregory G Grecco |
title |
Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry |
title_short |
Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry |
title_full |
Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry |
title_fullStr |
Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry |
title_full_unstemmed |
Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry |
title_sort |
prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry |
publisher |
eLife Sciences Publications Ltd |
series |
eLife |
issn |
2050-084X |
publishDate |
2021-03-01 |
description |
Despite the rising prevalence of methadone treatment in pregnant women with opioid use disorder, the effects of methadone on neurobehavioral development remain unclear. We developed a translational mouse model of prenatal methadone exposure (PME) that resembles the typical pattern of opioid use by pregnant women who first use oxycodone then switch to methadone maintenance pharmacotherapy, and subsequently become pregnant while maintained on methadone. We investigated the effects of PME on physical development, sensorimotor behavior, and motor neuron properties using a multidisciplinary approach of physical, biochemical, and behavioral assessments along with brain slice electrophysiology and in vivo magnetic resonance imaging. Methadone accumulated in the placenta and fetal brain, but methadone levels in offspring dropped rapidly at birth which was associated with symptoms and behaviors consistent with neonatal opioid withdrawal. PME produced substantial impairments in offspring physical growth, activity in an open field, and sensorimotor milestone acquisition. Furthermore, these behavioral alterations were associated with reduced neuronal density in the motor cortex and a disruption in motor neuron intrinsic properties and local circuit connectivity. The present study adds to the limited body of work examining PME by providing a comprehensive, translationally relevant characterization of how PME disrupts offspring physical and neurobehavioral development. |
topic |
prenatal opioid development behavior motor cortex |
url |
https://elifesciences.org/articles/66230 |
work_keys_str_mv |
AT gregoryggrecco prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT brianaemork prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT juiyenhuang prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT corinneemetzger prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT davidlhaggerty prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT kaitlincreeves prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT yonggao prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT hunterhoffman prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT simonnkatner prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT andrearmasters prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT cameronwmorris prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT erinanewell prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT ericaengleman prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT anthonyjbaucum prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT jiuenkim prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT bryankyamamoto prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT matthewrallen prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT yuchienwu prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT huichenlu prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT patricklsheets prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry AT bradykatwood prenatalmethadoneexposuredisruptsbehavioraldevelopmentandaltersmotorneuronintrinsicpropertiesandlocalcircuitry |
_version_ |
1721457509325078528 |
spelling |
doaj-5a76cf5be8ef4e9aa4a2a863c7ea37452021-05-05T22:53:48ZengeLife Sciences Publications LtdeLife2050-084X2021-03-011010.7554/eLife.66230Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitryGregory G Grecco0https://orcid.org/0000-0002-0700-8633Briana E Mork1https://orcid.org/0000-0002-5249-3738Jui-Yen Huang2https://orcid.org/0000-0003-4745-9970Corinne E Metzger3David L Haggerty4https://orcid.org/0000-0002-1455-2557Kaitlin C Reeves5Yong Gao6Hunter Hoffman7Simon N Katner8Andrea R Masters9Cameron W Morris10Erin A Newell11Eric A Engleman12Anthony J Baucum13Jiuen Kim14Bryan K Yamamoto15Matthew R Allen16Yu-Chien Wu17Hui-Chen Lu18https://orcid.org/0000-0002-6628-7177Patrick L Sheets19Brady K Atwood20https://orcid.org/0000-0002-7441-2724Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Indiana University School of Medicine, Medical Scientist Training Program, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Program in Medical Neuroscience, Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, United States; The Linda and Jack Gill Center for Biomolecular Sciences, Department of Psychological and Brain Science, Program in Neuroscience, Indiana University, Bloomington, United StatesDepartment of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United StatesDeparment of Psychiatry, Indiana University School of Medicine, Indianapolis, United StatesClinical Pharmacology Analytical Core-Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Department of Biology, Indiana University-Purdue University, Indianapolis, United StatesDeparment of Psychiatry, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Department of Biology, Indiana University-Purdue University, Indianapolis, United States; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, United States; Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, United StatesStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, United States; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Department of Psychological and Brain Sciences, Indiana University, Bloomington, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, United States; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, United StatesDespite the rising prevalence of methadone treatment in pregnant women with opioid use disorder, the effects of methadone on neurobehavioral development remain unclear. We developed a translational mouse model of prenatal methadone exposure (PME) that resembles the typical pattern of opioid use by pregnant women who first use oxycodone then switch to methadone maintenance pharmacotherapy, and subsequently become pregnant while maintained on methadone. We investigated the effects of PME on physical development, sensorimotor behavior, and motor neuron properties using a multidisciplinary approach of physical, biochemical, and behavioral assessments along with brain slice electrophysiology and in vivo magnetic resonance imaging. Methadone accumulated in the placenta and fetal brain, but methadone levels in offspring dropped rapidly at birth which was associated with symptoms and behaviors consistent with neonatal opioid withdrawal. PME produced substantial impairments in offspring physical growth, activity in an open field, and sensorimotor milestone acquisition. Furthermore, these behavioral alterations were associated with reduced neuronal density in the motor cortex and a disruption in motor neuron intrinsic properties and local circuit connectivity. The present study adds to the limited body of work examining PME by providing a comprehensive, translationally relevant characterization of how PME disrupts offspring physical and neurobehavioral development.https://elifesciences.org/articles/66230prenatal opioiddevelopmentbehaviormotor cortex |